# EQL Pharma – aktieanalysens källarkiv

Company page: https://spela.port0.org/company/eql-pharma
Company JSON: https://spela.port0.org/company/eql-pharma/company.json
Documents JSON: https://spela.port0.org/company/eql-pharma/documents.json
Updated: 2026-08-07T03:29:50Z

## Market data
- Nasdaq kurshistorik CSV: https://spela.port0.org/company/eql-pharma/market/history.csv
- Nasdaq kurshistorik JSON: https://spela.port0.org/company/eql-pharma/market/history.json
- Nasdaq manifest JSON: https://spela.port0.org/company/eql-pharma/market/manifest.json
- Nasdaq instrumentidentitet JSON: https://spela.port0.org/company/eql-pharma/market/instrument.json
- MFN manifest JSON: https://spela.port0.org/company/eql-pharma/market/mfn-manifest.json
- Nasdaq rapportmanifest JSON: https://spela.port0.org/company/eql-pharma/market/nasdaq-reports-manifest.json

## Financial reports
- Page: https://spela.port0.org/company/eql-pharma/reports
- JSON: https://spela.port0.org/company/eql-pharma/reports/reports.json
- 2026 Årsredovisning | Nasdaq Nordic | Årsredovisning 2026: https://view.news.eu.nasdaq.com/view?id=bce76992aa38bcf12986ce27193ba94fa&lang=sv&src=listed
- 2026 Q4 | MFN fallback | Kvartalsrapport Q4 2026: https://mfn.se/cis/a/eql-pharma/bokslutskommunike-april-2025-mars-2026-cd65bce1
- 2026 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2026: https://view.news.eu.nasdaq.com/view?id=bbe946ee124582ac108ed3da98d82996c&lang=sv&src=listed
- 2025 Årsredovisning | Nasdaq Nordic | Årsredovisning 2025: https://view.news.eu.nasdaq.com/view?id=bd91c525727fc0df0295d99befb524417&lang=sv&src=listed
- 2025 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2025: https://view.news.eu.nasdaq.com/view?id=b373d1ef2ff828bdf3c827517620fca18&lang=sv&src=listed
- 2025 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2025: https://view.news.eu.nasdaq.com/view?id=b84fd29d70f23162925698c018f18538f&lang=en&src=listed
- 2025 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2025: https://view.news.eu.nasdaq.com/view?id=b551840162d2f2fb02f90ddfb404de32d&lang=sv&src=listed
- 2025 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2025: https://view.news.eu.nasdaq.com/view?id=b189d065478acd84326e7dd4525a4b538&lang=sv&src=listed
- 2024 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2024: https://view.news.eu.nasdaq.com/view?id=b33f1714716c3ecac1a2d196442217fac&lang=sv&src=listed
- 2024 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2024: https://view.news.eu.nasdaq.com/view?id=b00bc27f31921715c1f87439b8ab2c90f&lang=en&src=listed
- 2024 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2024: https://view.news.eu.nasdaq.com/view?id=ba6acb8a9725523ec3eead0bd810d0fae&lang=sv&src=listed

## Finansinspektionen
- Page: https://spela.port0.org/company/eql-pharma/finansinspektionen
- Summary: https://spela.port0.org/company/eql-pharma/finansinspektionen/summary.json
- Insider transactions CSV: https://spela.port0.org/company/eql-pharma/finansinspektionen/insider-transactions.csv
- Insider transactions JSON: https://spela.port0.org/company/eql-pharma/finansinspektionen/insider-transactions.json
- Current short positions: https://spela.port0.org/company/eql-pharma/finansinspektionen/short-current.json
- Historical short positions: https://spela.port0.org/company/eql-pharma/finansinspektionen/short-history.json

## Full-text source documents
- Nasdaq Nordic | Årsredovisning 2026: https://spela.port0.org/company/eql-pharma/documents/nasdaq-nordic-arsredovisning-2026/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/eql-pharma/documents/nasdaq-nordic-arsredovisning-2026/part-001.html
  - HTML part 2: https://spela.port0.org/company/eql-pharma/documents/nasdaq-nordic-arsredovisning-2026/part-002.html
- MFN fallback | Kvartalsrapport Q4 2026: https://spela.port0.org/company/eql-pharma/documents/mfn-fallback-kvartalsrapport-q4-2026/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q4 2025: https://spela.port0.org/company/eql-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2026: https://spela.port0.org/company/eql-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2025: https://spela.port0.org/company/eql-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2025: https://spela.port0.org/company/eql-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2025: https://spela.port0.org/company/eql-pharma/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/eql-pharma/documents/nasdaq-nordic-arsredovisning-2025/part-001.html
  - HTML part 2: https://spela.port0.org/company/eql-pharma/documents/nasdaq-nordic-arsredovisning-2025/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2024: https://spela.port0.org/company/eql-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2025: https://spela.port0.org/company/eql-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2024: https://spela.port0.org/company/eql-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2024: https://spela.port0.org/company/eql-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt
- MFN | MFN bolagssida och bolagsmetadata: https://spela.port0.org/company/eql-pharma/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt